Paul Tudor Jones's AGL Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 32,230 shares of agilon health, inc. (AGL) worth $554,924, representing 0.00% of the portfolio. First purchased in 2022-Q3, this medium-term investment has been held for 14 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in AGL, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2024, adding 25,708 shares. Largest reduction occurred in Q3 2025, reducing 22,315 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's agilon health (AGL) Holding Value Over Time
Track share changes against reported price movement
Quarterly agilon health (AGL) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2025 | -22,315 | Reduce 40.91% | 32,230 | $25.75 |
| Q2 2025 | -6,363 | Reduce 10.45% | 54,545 | $57.50 |
| Q1 2025 | +135 | Add 0.22% | 60,908 | $108.25 |
| Q4 2024 | -506 | Reduce 0.83% | 60,773 | $47.50 |
| Q3 2024 | +11,240 | Add 22.46% | 61,279 | $98.25 |
| Q2 2024 | +1,075 | Add 2.20% | 50,039 | $163.50 |
| Q1 2024 | +25,708 | Add 110.55% | 48,964 | $152.50 |
| Q4 2023 | +18,183 | Add 358.43% | 23,256 | $313.75 |
| Q3 2023 | +126,823 | New Buy | 5,073 | $443.99 |
| Q2 2023 | -2,779 | Sold Out | 0 | $0.00 |
| Q1 2023 | +69,470 | New Buy | 2,779 | $0.59 |
| Q4 2022 | -1,806 | Sold Out | 0 | $0.00 |
| Q3 2022 | +45,149 | New Buy | 1,806 | $585.27 |
Paul Tudor Jones's agilon health Investment FAQs
Paul Tudor Jones first purchased agilon health, inc. (AGL) in Q3 2022, acquiring 1,806 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held agilon health, inc. (AGL) for 14 quarters since Q3 2022.
Paul Tudor Jones's largest addition to agilon health, inc. (AGL) was in Q3 2023, adding 5,073 shares worth $2.25 M.
According to the latest 13F filing for Q4 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 32,230 shares of agilon health, inc. (AGL), valued at approximately $554,924.
As of the Q4 2025 filing, agilon health, inc. (AGL) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in agilon health, inc. (AGL) was 61,279 shares, as reported at the end of Q3 2024.